ALVO · Company research
Alvotech Ordinary Shares (ALVO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A proposed Eylea biosimilar remains unapproved as Alvotech (ALVO) submits its European application. - Stock Titan | A proposed Eylea biosimilar remains unapproved as Alvotech (ALVO) submits its European application. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Did FDA Capacity Expansion Just Shift Alvotech (ALVO) Stock Narrative? - Simply Wall Street | Did FDA Capacity Expansion Just Shift Alvotech (ALVO) Stock Narrative? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 13, 2026 | neutral | 0 | 0.6 |
| Alvotech (NASDAQ:ALVO) Stock Has Consensus Target Price of $8.50 According to Brokerages - MarketBeat | Alvotech (NASDAQ:ALVO) Stock Has Consensus Target Price of $8.50 According to Brokerages MarketBeat | View source ↗ | MarketBeat | Oct 13, 2026 | neutral | 0 | 0.6 |
| Understanding Momentum Shifts in (ALVO) - Stock Traders Daily | Understanding Momentum Shifts in (ALVO) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| Manufacturing Approval Could Change The Case For Alvotech (ALVO) Stock - Simply Wall Street | Manufacturing Approval Could Change The Case For Alvotech (ALVO) Stock Simply Wall Street | View source ↗ | Simply Wall Street | Oct 6, 2026 | neutral | 0 | 0.6 |
| Alvotech (NASDAQ:ALVO) Shares Gap Up - Still a Buy? - MarketBeat | Alvotech (NASDAQ:ALVO) Shares Gap Up - Still a Buy? MarketBeat | View source ↗ | MarketBeat | Oct 5, 2026 | neutral | 0 | 0.6 |
| FDA approval lets Alvotech double capacity to make a Humira alternative for U.S. supply - Stock Titan | FDA approval lets Alvotech double capacity to make a Humira alternative for U.S. supply Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| A New York plant will make ingredients for medicines closely matched to drugs made from living cells. - Stock Titan | A New York plant will make ingredients for medicines closely matched to drugs made from living cells. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Alvotech (NASDAQ:ALVO) Shares Up 3.5% - Here's What Happened - MarketBeat | Alvotech (NASDAQ:ALVO) Shares Up 3.5% - Here's What Happened MarketBeat | View source ↗ | MarketBeat | Sep 24, 2026 | neutral | 0 | 0.6 |
| ALVO Stock Jumps On Double Upgrade — Why Barclays Sees A 59% Upside - Stocktwits | ALVO Stock Jumps On Double Upgrade — Why Barclays Sees A 59% Upside Stocktwits | View source ↗ | Stocktwits | Sep 16, 2026 | neutral | 0 | 0.6 |
| Alvotech advances 18%, accelerating post-earnings rally (ALVO:NASDAQ) - Seeking Alpha | Alvotech advances 18%, accelerating post-earnings rally (ALVO:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 24, 2026 | neutral | 0 | 0.6 |
| Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow? - Yahoo Finance | Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 24, 2026 | neutral | 0 | 0.6 |
| Alvotech (ALVO) Stock Rises On Guidance Resolve Despite Lingering Loss Risk - Simply Wall Street | Alvotech (ALVO) Stock Rises On Guidance Resolve Despite Lingering Loss Risk Simply Wall Street | View source ↗ | Simply Wall Street | Aug 20, 2026 | neutral | 0 | 0.6 |
| ALVOTECH ($ALVO) Releases Q2 2026 Earnings | ALVO Stock News - Quiver Quantitative | ALVOTECH ($ALVO) Releases Q2 2026 Earnings | ALVO Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 19, 2026 | neutral | 0 | 0.6 |
| Alvotech (ALVO) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance | Alvotech (ALVO) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 19, 2026 | neutral | 0 | 0.6 |
| ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - Yahoo Finance | ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs Yahoo Finance | View source ↗ | Yahoo Finance | Jun 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.